Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been suspected of having or have been diagnosed with myasthenia gravis (a condition that causes muscle weakness), whether it affects only your eyes or your whole body
- You have already had, or are planned to have, blood tests to check for specific antibodies linked to myasthenia gravis (called anti-AChR and anti-MuSK antibodies)
- Your myasthenia gravis symptoms are at least at a minimum level of severity, as measured by a standard rating scale used by myasthenia gravis specialists
Who may not be able to join:
- You are currently having serious breathing problems
- You are experiencing severe difficulties with swallowing or speaking due to your condition
- You are taking medications that could make nerve-to-muscle communication worse (confirm with trial site)
- You currently have an active infection
- You have another condition affecting your nerves or muscles (such as polyneuropathy or myopathy) that could affect the results of physical fatigue tests
- You have cognitive or behavioral difficulties that might make it hard to follow the study's requirements
- You are currently taking steroid medications to treat your myasthenia gravis
- Your myasthenia gravis is severe enough that it would be unsafe to stop taking a type of medication called acetylcholinesterase inhibitors (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jakub M Antczak, MD, Jagiellonian University Medical College, Department of Neurology
Phone: +48 795 421 153
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in the highest decrement between investigation of nasalis during morning and evening RNS; Difference in the highest decrement between investigation of trapezius during morning and evening RNS; Difference in the highest decrement between investigation of nasalis during morning RNS with single and with two voluntary efforts; Difference in the highest decrement between investigation of trapezius during morning RNS with single and with two voluntary efforts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.